Sanofi to Buy Medley

April 9, 2009
Medley specializes in generic treatments

French pharmaceutical group Sanofi Aventis said on April 9 it will acquire Brazil's Medley, a specialist in generic treatments, for $665 million (500 million euros.)

Medley, ranked third in Brazil, posted 2008 sales of some 150 million euros, two thirds of which were accounted for by generic drugs -- those on which patents have lapsed.

"This acquisition will allow Sanofi Aventis to strengthen its number one position in Brazil," the company said.

Copyright Agence France-Presse, 2009

About the Author

Agence France-Presse

Copyright Agence France-Presse, 2002-2024. AFP text, photos, graphics and logos shall not be reproduced, published, broadcast, rewritten for broadcast or publication or redistributed directly or indirectly in any medium. AFP shall not be held liable for any delays, inaccuracies, errors or omissions in any AFP content, or for any actions taken in consequence.

Sponsored Recommendations

Voice your opinion!

To join the conversation, and become an exclusive member of IndustryWeek, create an account today!